Mandy Vink, VP of Business Development at Codexis, explains how the company leverages over 20 years of expertise in small-molecule APIs to advance biocatalysis across pharma.
Mandy Vink
Advertisement
Articles by Mandy Vink
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
3
Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026
4
Johnson & Johnson’s Tecvayli Combo Wins FDA National Priority Voucher
5